Your Cart ( 1 Item )

• Topical Aprepitant (HT-001): A Novel Therapy for Epidermal Growth Factor Receptor Inhibitor-Associated Papulopustular Eruptions
  September 2024 | Volume 23 | Issue 9 | Case Reports | e173 | Copyright © September 2024
  Nikita Menta BA, Savanna I. Vidal BS, Adam Friedman MD FAAD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs